Epitheliotrophe Kapazität von Serum- und Plasmaaugentropfen

[1]  G. Geerling,et al.  Autologe Serum-Augentropfen zur Therapie der Augenoberfläche , 2002, Der Ophthalmologe.

[2]  C. Creuzot-Garcher,et al.  Treatment of Persistent Corneal Epithelial Defects by Autologous Serum , 2002 .

[3]  K. Tsubota,et al.  Treatment of Superior Limbic Keratoconjunctivitis by Application of Autologous Serum , 2001, Cornea.

[4]  B. Seitz,et al.  Autologes Serum bei sonst therapieresistenten Hornhautepitheldefekten - Prospektive Studie an den ersten 70 Augen , 2001 .

[5]  J. Daniels,et al.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies , 2001, The British journal of ophthalmology.

[6]  P. Khaw,et al.  Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. , 2001, Investigative ophthalmology & visual science.

[7]  S. Horiuchi,et al.  Advanced glycation end products in Descemet’s membrane and their effect on corneal endothelial cell , 2001, Current eye research.

[8]  M. Yamada,et al.  Decreased substance P concentrations in tears from patients with corneal hypesthesia. , 2000, American journal of ophthalmology.

[9]  C. Sotozono,et al.  Growth factors: importance in wound healing and maintenance of transparency of the cornea , 2000, Progress in Retinal and Eye Research.

[10]  K. Tsubota,et al.  Treatment of persistent corneal epithelial defect by autologous serum application. , 1999, Ophthalmology.

[11]  S. Wilson,et al.  Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. , 1999, Investigative ophthalmology & visual science.

[12]  K. Tsubota,et al.  Treatment of dry eye by autologous serum application in Sjögren’s syndrome , 1998, The British journal of ophthalmology.

[13]  W. Kao,et al.  Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice. , 1997, Investigative ophthalmology & visual science.

[14]  S. Krane,et al.  The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix , 1997, The Journal of cell biology.

[15]  R. Lavker,et al.  EGF-R dependent regulation of keratinocyte survival. , 1997, Journal of cell science.

[16]  C. Murphy,et al.  Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea , 1996, Journal of cellular physiology.

[17]  B. Holden,et al.  Fibronectin in the tear film. , 1996, Investigative ophthalmology & visual science.

[18]  Y. Tano,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[19]  M. Nieto,et al.  Growth factors as survival factors: Regulation of apoptosis , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  J. Ubels,et al.  Artificial Tear Composition and Promotion of Recovery of the Damaged Corneal Epithelium , 1993, Cornea.

[21]  J. F. Gordon,et al.  Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group. , 1992, American journal of ophthalmology.

[22]  J. Pastor,et al.  Epidermal Growth Factor and Corneal Wound Healing: A Multicenter Study , 1992, Cornea.

[23]  W. O'brien,et al.  Retinoic acid decreases the number of EGF receptors in corneal epithelium and Chang conjunctival cells. , 1991, Experimental eye research.

[24]  S. Kinoshita,et al.  The mechanism of accelerated corneal epithelial healing by human epidermal growth factor. , 1990, Investigative ophthalmology & visual science.

[25]  P. McDonnell,et al.  Immunoglobulin deposition in the cornea after application of autologous serum. , 1988, Archives of ophthalmology.

[26]  J. Belmont,et al.  Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. , 1984, Arthritis and rheumatism.

[27]  T. Awata,et al.  Fibronectin. A new therapy for corneal trophic ulcer. , 1983, Archives of ophthalmology.

[28]  K. Hayashi,et al.  An SV 40-Immortalized Human Corneal Epithelial Cell Line and Its Characterization , 2005 .

[29]  K. Barton,et al.  Cytokines and tear function in ocular surface disease. , 1998, Advances in experimental medicine and biology.

[30]  A. Gazzaniga,et al.  Epidermal growth factor in the topical treatment of herpetic corneal ulcers. , 1994, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[31]  A. Gazzaniga,et al.  Epidermal growth factor in the topical treatment of traumatic corneal ulcers. , 1993, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[32]  C. Baudouin,et al.  Effects of aFGF and bFGF on wound healing in rabbit corneas. , 1987, Current eye research.